The British Journal of Psychiatry (2009) 195: S5-S6. doi: 10.1192/bjp.195.52.s5
© 2009 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Burns, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burns, T.

EDITORIALS

Knowledge about antipsychotic long-acting injections: bridging that gap

Tom Burns, DSc, FRCPsych

Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX, UK. Email: tom.burns{at}psych.ox.ac.uk

Declaration of interest

None.

Antipsychotics in depot (or `long-acting injection', LAI) form are shown in this supplement to be a significant component of clinical practice. They are comparatively underresearched, which may reflect their frequent use witih poorly adherent patients. This supplement clearly demonstrates the need for that research, highlighting the variations in dosing and the absence of established, specific guidelines in their use. Traditional evidence-based approaches to systematic reviews are of limited utility in this area so this supplement's blending of experimental trials with observational research is particularly appropriate and effective. After a brief decline in their use with the introduction of oral atypical antipsychotics, LAIs are regaining a central position in the care of long-term psychosis. This comprehensive review of current knowledge makes a timely contribution.